WHO ICTRP trial
The novel effect of avatrombopag in the management of refractory chemotherapy…
ChiCTR2100050646 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100050646 |
|---|---|
| Public title | The novel effect of avatrombopag in the management of refractory chemotherapy induced thrombocytopenia (CIT) in patients with solid tumors: a single arm study |
| Scientific title | The novel effect of avatrombopag in the management of refractory chemotherapy induced thrombocytopenia (CIT) in patients with solid tumors: a single arm study |
| Primary sponsor | Zhejiang Provincial Hospital of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | refractory chemotherapy induced thrombocytopenia |
| Interventions | experimental group:avatrombopag |
| Registration date | Sep 1, 2021 |
| Target size | experimental group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: